ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Stavros P. Papadakos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1583-1125; OpenAlex author ID A5061095280. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580 ↗
The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. Co-author DOI 10.3390/ijms24033015 ↗
Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment? Co-author DOI 10.3390/ijms23073620 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Stamatios E Theocharis · 2 shared papers, 2022–2023 · strength 0.44
- Paper The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. DOI 10.3390/ijms24033015 ↗
- Paper Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment? DOI 10.3390/ijms23073620 ↗
Maria Gazouli · 1 shared paper, 2022 · strength 0.20
- Paper Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment? DOI 10.3390/ijms23073620 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.